Home > Insider Trading > Filing (0001104659-22-114412)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1657312	Verona Pharma Plc	VRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408502	W Mark Hahn	3 More London Riverside London X0 SE1 2RE	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2022-11-01	454,856	$1.60	17,458,640	No	4	F	Direct
Ordinary Shares	Disposition	2022-11-01	13,160	$1.67	17,445,480	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2022 divided by eight (8).
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
The price reported represents the sale price of the ADSs divided by eight (8).
Consists of (i) 9,413,016 Ordinary Shares underlying RSUs (which are represented by 1,176,627 ADSs); and (ii) 8,032,464 Ordinary Shares underlying 1,004,058 ADSs.